Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 292

1.

Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2/ARE signaling pathway.

Lou H, Jing X, Wei X, Shi H, Ren D, Zhang X.

Neuropharmacology. 2014 Apr;79:380-8. doi: 10.1016/j.neuropharm.2013.11.026. Epub 2013 Dec 11.

PMID:
24333330
2.

Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity.

Jing X, Shi H, Zhang C, Ren M, Han M, Wei X, Zhang X, Lou H.

Neuroscience. 2015 Feb 12;286:131-40. doi: 10.1016/j.neuroscience.2014.11.047. Epub 2014 Nov 29.

PMID:
25449120
3.

Tanshinone IIA protects dopaminergic neurons against 6-hydroxydopamine-induced neurotoxicity through miR-153/NF-E2-related factor 2/antioxidant response element signaling pathway.

Zhang XS, Ha S, Wang XL, Shi YL, Duan SS, Li ZA.

Neuroscience. 2015 Sep 10;303:489-502. doi: 10.1016/j.neuroscience.2015.06.030. Epub 2015 Jun 23.

PMID:
26116522
4.

Neuroprotection against 6-OHDA-induced oxidative stress and apoptosis in SH-SY5Y cells by 5,7-Dihydroxychromone: Activation of the Nrf2/ARE pathway.

Kim DW, Lee KT, Kwon J, Lee HJ, Lee D, Mar W.

Life Sci. 2015 Jun 1;130:25-30. doi: 10.1016/j.lfs.2015.02.026. Epub 2015 Mar 26.

PMID:
25818191
5.

Pinocembrin attenuates 6-OHDA-induced neuronal cell death through Nrf2/ARE pathway in SH-SY5Y cells.

Jin X, Liu Q, Jia L, Li M, Wang X.

Cell Mol Neurobiol. 2015 Apr;35(3):323-33. doi: 10.1007/s10571-014-0128-8. Epub 2014 Nov 7.

PMID:
25377066
6.

Involvement of activation of the Nrf2/ARE pathway in protection against 6-OHDA-induced SH-SY5Y cell death by α-iso-cubebenol.

Park SY, Kim do Y, Kang JK, Park G, Choi YW.

Neurotoxicology. 2014 Sep;44:160-8. doi: 10.1016/j.neuro.2014.06.011. Epub 2014 Jul 2.

PMID:
24997245
7.

Baicalein protects against 6-OHDA-induced neurotoxicity through activation of Keap1/Nrf2/HO-1 and involving PKCα and PI3K/AKT signaling pathways.

Zhang Z, Cui W, Li G, Yuan S, Xu D, Hoi MP, Lin Z, Dou J, Han Y, Lee SM.

J Agric Food Chem. 2012 Aug 22;60(33):8171-82. doi: 10.1021/jf301511m. Epub 2012 Aug 9.

PMID:
22838648
8.

Methylparaben protects 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells and improved behavioral impairments in mouse model of Parkinson's disease.

Kopalli SR, Noh SJ, Koppula S, Suh YH.

Neurotoxicology. 2013 Jan;34:25-32. doi: 10.1016/j.neuro.2012.10.003. Epub 2012 Oct 12.

PMID:
23068419
9.

Danshensu protects against 6-hydroxydopamine-induced damage of PC12 cells in vitro and dopaminergic neurons in zebrafish.

Chong CM, Zhou ZY, Razmovski-Naumovski V, Cui GZ, Zhang LQ, Sa F, Hoi PM, Chan K, Lee SM.

Neurosci Lett. 2013 May 24;543:121-5. doi: 10.1016/j.neulet.2013.02.069. Epub 2013 Apr 3.

PMID:
23562886
10.

Licochalcone E activates Nrf2/antioxidant response element signaling pathway in both neuronal and microglial cells: therapeutic relevance to neurodegenerative disease.

Kim SS, Lim J, Bang Y, Gal J, Lee SU, Cho YC, Yoon G, Kang BY, Cheon SH, Choi HJ.

J Nutr Biochem. 2012 Oct;23(10):1314-23. doi: 10.1016/j.jnutbio.2011.07.012. Epub 2012 Jan 5.

PMID:
22227268
11.

3,4-dihydroxybenzalacetone protects against Parkinson's disease-related neurotoxin 6-OHDA through Akt/Nrf2/glutathione pathway.

Gunjima K, Tomiyama R, Takakura K, Yamada T, Hashida K, Nakamura Y, Konishi T, Matsugo S, Hori O.

J Cell Biochem. 2014 Jan;115(1):151-60. doi: 10.1002/jcb.24643.

PMID:
23959789
12.

Nrf2 signaling contributes to the neuroprotective effects of urate against 6-OHDA toxicity.

Zhang N, Shu HY, Huang T, Zhang QL, Li D, Zhang GQ, Peng XY, Liu CF, Luo WF, Hu LF.

PLoS One. 2014 Jun 24;9(6):e100286. doi: 10.1371/journal.pone.0100286. eCollection 2014.

13.

Nrf2 activators provide neuroprotection against 6-hydroxydopamine toxicity in rat organotypic nigrostriatal cocultures.

Siebert A, Desai V, Chandrasekaran K, Fiskum G, Jafri MS.

J Neurosci Res. 2009 May 15;87(7):1659-69. doi: 10.1002/jnr.21975.

PMID:
19125416
14.

Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro.

Mu X, He G, Cheng Y, Li X, Xu B, Du G.

Pharmacol Biochem Behav. 2009 Jun;92(4):642-8. doi: 10.1016/j.pbb.2009.03.008. Epub 2009 Mar 25.

PMID:
19327378
15.

Neuroprotective effects of TEMPOL in central and peripheral nervous system models of Parkinson's disease.

Liang Q, Smith AD, Pan S, Tyurin VA, Kagan VE, Hastings TG, Schor NF.

Biochem Pharmacol. 2005 Nov 1;70(9):1371-81.

PMID:
16144694
16.

Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

Chaturvedi RK, Shukla S, Seth K, Chauhan S, Sinha C, Shukla Y, Agrawal AK.

Neurobiol Dis. 2006 May;22(2):421-34. Epub 2006 Feb 9.

PMID:
16480889
17.

S-allyl cysteine activates the Nrf2-dependent antioxidant response and protects neurons against ischemic injury in vitro and in vivo.

Shi H, Jing X, Wei X, Perez RG, Ren M, Zhang X, Lou H.

J Neurochem. 2015 Apr;133(2):298-308. doi: 10.1111/jnc.12986. Epub 2015 Jan 23.

18.

Protection against dopaminergic neurodegeneration in Parkinson's disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7.

Inden M, Kitamura Y, Takahashi K, Takata K, Ito N, Niwa R, Funayama R, Nishimura K, Taniguchi T, Honda T, Taira T, Ariga H.

J Pharmacol Sci. 2011;117(3):189-203. Epub 2011 Oct 29.

19.

6-OHDA-induced apoptosis and mitochondrial dysfunction are mediated by early modulation of intracellular signals and interaction of Nrf2 and NF-κB factors.

Tobón-Velasco JC, Limón-Pacheco JH, Orozco-Ibarra M, Macías-Silva M, Vázquez-Victorio G, Cuevas E, Ali SF, Cuadrado A, Pedraza-Chaverrí J, Santamaría A.

Toxicology. 2013 Feb 8;304:109-19. doi: 10.1016/j.tox.2012.12.011. Epub 2012 Dec 26.

PMID:
23274087
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk